FX1
Cat. No.：YN270041
CAS No. ：1426138-42-2
| 产品名称: | FX1 |
| CAS No.: | 1426138-42-2 |
| Chemical Name: | (5Z)-5-(5-chloro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinepropanoic acid |
| Synonyms: | (5Z)-5-(5-Chloro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)-4-oxo-2-thioxo-3-thiazolidinepropanoic acid;(Z)-3-(5-(5-Chloro-2-oxoindolin-3-ylidene)-4-oxo-2-thioxothiazolidin-3-yl)propanoic acid;FX1;FX 1;BCP20471;s8591;AK00783069;3-[5-(5-Chloro-2-oxoindol-3-yl)- |
| 分子量: | 368.82 |
| 分子式: | C₁₄H₉ClN₂O₄S₂ |
| SMILES: | O=C(O)CCN(C/1=O)C(SC1=C2C(NC3=C/2C=C(Cl)C=C3)=O)=S |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | FX1 是一种强效且特异性的BCL6抑制剂，IC50大约为 35 μM。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Cardenas, M.G., Yu, W., Beguelin, W., et al.Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphomaJ. Clin. Invest.126(9),3351-3362(2016)
